#USA #New York #digital health #DarioHealth #cardiometabolic suite

DarioHealth Expands Its Reach with New Contracts

DarioHealth Corp., recognized as a frontrunner in the digital health sector, has secured five new employer contracts that underscore its expanding footprint in the industry. These contracts, which came into effect in Q2 and Q3 of 2025, are pivotal in supporting Dario's mission to deliver comprehensive digital health solutions for chronic conditions, including prediabetes, diabetes, and hypertension. The introduction of these programs is particularly significant as they will impact a total of 107,000 lives, further solidifying Dario's B2B2C strategy and driving its recurring revenue growth.

The company's President and Chief Commercial Officer, Steven Nelson, emphasized that these employer contracts are a crucial element in Dario's strategy for achieving short-term growth. He stated, "We believe that employer contracts continue to be a powerful driver of near-term growth for Dario." With a robust pipeline worth $67 million across various clients, including health plans and pharmaceutical clients, Dario is poised for notable expansion.

One of the significant highlights of this announcement is that among the new contracts, one is with Dario's largest employer client to date. This partnership not only marks a milestone for Dario but also reflects the increasing demand for multi-condition programs that utilize digital health innovations. Notably, a staggering 80% of new accounts established in 2025 focus on multi-condition initiatives, demonstrating the company's commitment to providing holistic care solutions.

Dario's cardiometabolic suite is noteworthy for its proven effectiveness. Its strategies have demonstrated a promising track record: a reduction of 1.4% in eHbA1c levels among diabetes users, a 10% decrease in body mass index for prediabetes members, and a significant 38% of hypertension clients achieving reduced blood pressure levels. These measurable outcomes are the result of Dario's comprehensive approach, which includes user-friendly devices that provide individuals with the tools needed to manage their health effectively.

Moreover, the business model not only focuses on health outcomes but also alleviates financial burdens for employers. Research indicates that Dario's solutions can lead to employer savings of up to $5,000 per user by decreasing hospitalizations by 23% and healthcare utilization by 9%. This combination of health improvement and cost reduction is appealing to employers who seek to enhance the well-being of their workforce.

DarioHealth’s unique approach to digital therapeutics combines data analytics and personalized coaching, fostering a more engaged experience for users battling chronic conditions. The company’s commitment to providing a user-centric platform represents a shift away from traditional healthcare models, focusing on long-term behavior change and lifestyle adaptation for sustainable health management.

In conclusion, DarioHealth's recent achievements in securing contracts and expanding its service offerings highlight a significant step forward in the digital health landscape. With its innovative solutions tailored for chronic conditions and a focus on both patient care and employer efficiency, Dario is positioned to continue its trajectory of success and growth in the digital healthcare arena. Those interested in learning more about Dario's offerings and its impact on improving health outcomes can visit DarioHealth's website.